8-KThe WireStrategic
Material Agreement · Reg FD Disclosure
Filed Oct 3, 2022 · 3y ago · Accession 0001575872-22-000912
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Estrella Immunopharma, Inc.
- Ticker
- ESLAW
- CIK
- 1844417
- Form type
- 8-K
- Filing date
- Oct 3, 2022
- Report date
- Sep 30, 2022
- Document
- uptd-20220930.htm
- Size
- 1.7 MB